30 Top Biotech Startups Revolutionizing the Industry in 2024

Biotechnology companies utilize the power of tech to develop innovative solutions in various fields, including healthcare, agriculture, and environmental conservation. These are the best biotech startups at the forefront of scientific innovation; their groundbreaking work holds the potential to revolutionize industries and improve lives worldwide.

Disclaimer: With so many new biotech startups launching and growing worldwide, we aren’t able to cover them all. Furthermore, the startups that are listed below are not officially ranked and are listed in no particular order.

• Location: Guilford, Connecticut
• Founders: Jonathan Rothberg
• Founded In: 2017
• Funding: Series C, Undisclosed
• Investors Include: US Department of Health and Human Services, Expa, Human Capital

Detect is a technology company that utilizes the power of artificial intelligence to discover impactful, innovative biotechnology tools such as rapid PCR testing for COVID-19 as well as other industry-shifting, accessible diagnostic tools.

• Location: Boston, Massachusetts
• Founders: Ian Collins, Raj Chopra
• Founded In: 2018
• Funding: Post-IPO Equity, $248.5 Million
• Investors Include: Avoro Capital Advisors, Amzak Health Investors, Cormorant Asset Management

Monte Rosa Therapeutics provides innovative cancer therapeutics that modulate protein degradation pathways by targeting disease-creating proteins to create a more effective treatment option.

• Location: Dallas, Texas
• Founders: Ben Lamm, Dr. George Church
• Founded In: 2021
• Funding: Undisclosed, $235.5 Million
• Investors Include: Draper Associates, Animoca Brands, Boost VC

Colossal is a bioscience startup pioneering innovative techniques in genetic engineering and conservation biology. The company aims to restore extinct species like the woolly mammoth and the Tasmanian tiger to their natural habitats, contributing to biodiversity and combating climate change.

• Location: Irvine, California
• Founders: Keith Katkin
• Founded In: 2017
• Funding: Debt Financing, $100 Million
• Investors Include: Hercules Capital

Urovant Sciences is a biotech and drug discovery company that develops a variety of alternative, innovative therapies for urologic conditions.

• Location: Vancouver, Canada
• Founders: Ross Haghighat
• Founded In: 2019
• Funding: Post-IPO Equity, $171 Million
• Investors Include: OrbiMed, Avidity Partners, Versant Ventures

Chinook Therapeutics is a clinical-stage biotechnology company that develops precision medicine for chronic kidney illnesses, specifically rare and severe conditions.

Recommended: Check out our full list of the top startups to watch in 2024!

• Location: Salt Lake City, Utah
• Founders: Blake Borgeson, Chris Gibson, Dean Li
• Founded In: 2013
• Funding: Post-IPO Equity, $665.4 Million
• Investors Include: Leaps by Bayer, Advantage Capital, Two Sigma Ventures

Recursion Pharmaceuticals is a clinical-stage biotech and drug-development company that utilizes the capabilities of machine-learning technology to offer an innovative drug-discovery platform and pipeline.

Feeling inspired? Learn how to launch your company with our guide on how to start a startup.

• Location: Waltham, Massachusetts
• Founders: David Hallal, Mitchell Finer, Vikas Sinha
• Founded In: 2017
• Funding: Undisclosed, $1.2 Billion
• Investors Include: Emerson Collective, EDBI, Surveyor Capital

ElevateBio is a portfolio of impactful, inventive biotechnology companies specializing in gene and cell therapies that are utilized to develop new medicines and treatments.

• Location: Boston, Massachusetts
• Founders: Andrew Miller
• Founded In: 2009
• Funding: Post-IPO Equity, $1.6 Billion
• Investors Include: ARCH Venture Partners, PureTech Health, Alexandria Venture Investments

Karuna Therapeutics aims to provide patients with psychiatric and neurological conditions with effective treatments in order to combat the unmet needs of these communities.

• Location: San Diego, California
• Founders: Ayub Khattak, Clint Sever
• Founded In: 2010
• Funding: Grant, $899.6 Million
• Investors Include: Biomedical Advanced Research and Development Authority (BARDA), US Department of Health & Human Services

With accessible diagnostics at the forefront of the biotech industry, Cue Health has been paving the way since 2010 to provide patients with the tools and resources to effectively manage their own health through at-home diagnostics.

• Location: Houston, Texas
• Founders: Michael Stewart
• Founded In: 2016
• Funding: Undisclosed
• Investors Include: 2bPrecise

AccessDx Lab is one of the trusted leaders in COVID-19 testing. This, in combination with their various other infectious disease testing options, is essential for providing care teams with more impactful and efficient diagnostic tools.

• Location: Watertown, Massachusetts
• Founders: Mark Bamforth
• Founded In: 2019
• Funding: Undisclosed, $82 Million
• Investors Include: Ampersand Capital Partners

Arranta Bio is a contract development and manufacturing organization (CDMO) that partners with biotech companies to generate therapeutic solutions.

• Location: Houston, Texas
• Founders: Ann Leen, Cliona Rooney, Helen Heslop, John Wilson, Juan Vera, Malcolm Brenner
• Founded In: 2013
• Funding: Post-IPO Equity, $360.6 Million
• Investors Include: EcoR1 Capital, Invus

AlloVir creates off-the-shelf, virus-specific T-cell (VST) therapies to treat and prevent the spread of infectious diseases for patients with T-cell deficiencies and therefore limited treatment options.

• Location: Branford, Connecticut
• Founders: Ann Leen, Cliona Rooney, Helen Heslop, John Wilson, Juan Vera, Malcolm Brenner
• Founded In: 2013
• Funding: Series D, $205.1 Million
• Investors Include: Fidelity Management and Research Company, Kite Pharma, GMT Capital

IsoPlexis is dedicated to creating life-changing medications. Its innovative tools and systems help accelerate the generation of medications for faster access to better treatment options.

• Location: Burlingame, California
• Founders: Nish Bhat, Othman Laraki, Sanem Fabri, Taylor Sittler
• Founded In: 2013
• Funding: Series E, $482 Million
• Investors Include: T. Rowe Price, Kindred Ventures, General Catalyst

Color is a healthcare platform and operating system that aims to make large-scale health initiatives easier to scale and implement through software and infrastructure options that work for companies, public health agencies, and more.

• Location: San Francisco, California
• Founders: Ashutosh Singhal, Cory Li, Sajith Wickramasekara
• Founded In: 2012
• Funding: Series F, $411.9 Million
• Investors Include: Altimeter Capital, Franklin Templeton Investments

Benchling is a biotech company made for biotech companies. Its cloud-software platform is created for the use of researchers and research and development organizations.

• Location: Vancouver, Washington
• Founders: Sean McClain
• Founded In: 2011
• Funding: Venture, $237.9 Million
• Investors Include: Redmile Group, Casdin Capital, Merck Global Health Innovation Fund

Absci incorporates artificial intelligence with synthetic biotechnology to discover and develop therapies through proteins.

• Location: Philadelphia, Pennsylvania
• Founders: James Wilson
• Founded In: 2018
• Funding: Post-IPO Equity, $379.5 Million
• Investors Include: Len Blavatnik, Highline Capital Management, Lilly Asia Ventures

Passage Bio leverages the insight and capabilities of gene therapy to develop new and powerful medications. Through its partnership with Pennsylvania’s Gene Therapy Program (GTP), this company is able to research and develop life-changing medications and treatments.

• Location: Boston, Massachusetts
• Founders: Anthony Philippakis, Barry Ticho, Burt Adelman, Issi Rozen, J. Keith Joung, Kiran Musunuru, Sekar Kathiresan
• Founded In: 2018
• Funding: Post-IPO Equity, $400.5 Million
• Investors Include: Wellington Management, Casdin Capital

Verve Therapeutics is taking on cardiovascular disease, the world’s most common cause of death, with gene-editing medications for patients at risk for cardiovascular disease.

• Location: Silicon Valley (San Mateo, California)
• Founders: Angela Koehler, Christopher Wilfong, Joshua Kazam
• Founded In: 2017
• Funding: Private Equity, $278 Million
• Investors Include: Vida Ventures, Commodore Capital, Woodline Partners

Kronos Bio is a clinical-stage biotechnology company working hard to discover and develop cancer-fighting medications by targeting dysregulated transcription factors. The company’s primary focus is the treatment of leukemia and MYC-dependent solid tumors.

• Location: Burlingame, California
• Founders: Jonathan Romanowsky, Purvesh Khatri, Tim Sweeney
• Founded In: 2016
• Funding: Grant, $137.8 Million
• Investors Include: National Institutes of Health, D1 Capital Partners, DARPA

Inflammatix is a biotechnology company that has developed tech to gauge patients’ immune response to infections to inform better diagnostic and treatment options safely and easily.

• Location: New York, New York
• Founders: Alan Murray, Jeffrey Port, Joshua Abram
• Founded In: 2018
• Funding: Angel, $153.5 Million
• Investors Include: Presight Capital, 5AM Ventures, Casdin Capital

TMRW Life Sciences is a startup pioneering the world’s first and only automated platform for the care and management of frozen embryos and eggs to be used in IVF. By using their technology and IVF management solutions, the risk of misidentifying or losing embryos or eggs in IVF is reduced significantly.

• Location: South San Francisco, California
• Founders: Charles Homcy
• Founded In: 2018
• Funding: Venture, $381 Million
• Investors Include: Matrix Capital Management, NS Investment, Woodline Partners

Maze Therapeutics is a biotechnology company that’s working on translating genetic insights into various therapeutic innovations and treating disease by harnessing the ultimate power of human genetics. The human genome can be imagined as a complex maze, and by navigating this maze, it is possible to create precision medicines that help patients and effectively fight disease.

• Location: Somerville, Massachusetts
• Founders: Avak Kahvejian, Jim Collins, Nick Plugis, Noubar Afeyan
• Founded In: 2017
• Funding: Series C, $294 Million
• Investors Include: Flagship Pioneering, BlackRock, The Baupost Group

Cellarity is an innovative startup in the biotech space that’s working on pioneering new therapeutics across multiple different types of diseases by understanding, targeting, and then changing behaviors of key cells. They are combining high-resolution cell data with machine learning algorithms to develop new medicines that are built entirely from a cell-centric model.

• Location: Los Angeles, California
• Founders: Aviad Maizels, Michael Shpigelmacher
• Founded In: 2016
• Funding: Series B, $63.2 Million
• Investors Include: Khosla Ventures, Bioverge, Sixty Degree Capital

Bionaut Labs is reimagining therapeutics and revolutionizing treatments related to central nervous system (CNS) disorders. The unique aspect of their approach is the use of remote-controlled micro-robots that they call “Bionauts,” which, in time, will be able to help patients who are suffering from brain diseases and don’t have very many treatment options remaining.

• Location: Palo Alto, California
• Founders: Fraser Wright, Roger Jeffs, Shankar Ramaswamy
• Founded In: 2019
• Funding: Series C, $600.5 Million
• Investors Include: CAM Capital, Alumni Ventures, Bluebird Ventures

Kriya Therapeutics is a biotechnology startup working to unleash the full power of gene therapy and redefine how they are designed, developed, and manufactured today. Their goal is to reduce production and development costs and improve the speed of marketing gene-helpful therapies, expanding their range to various diseases.

• Location: Cambridge, Massachusetts
• Founders: Alex Wesselhoeft, Daniel Anderson, Raffaella Squilloni
• Founded In: 2019
• Funding: Series B, $321 Million
• Investors Include: MPM Capital, Merck, F2 Ventures, Taiho Ventures

Orna Therapeutics is developing an entirely new class of RNA medicines called “oRNA” circular RNAs. Their new methodology is positioned to change the way we currently treat disease and works by combining innovative delivery techniques with “oRNA” circular RNAs. The treatments afforded by this technology could potentially impact regenerative medicine, cancer, infectious diseases, autoimmunity, and protein replacement.

• Location: San Diego, California
• Founders: Osman Kibar
• Founded In: 2008
• Funding: Venture, $778 Million
• Investors Include: Eventide, aMoon Fund, Starling Group

Biosplice Therapeutics is using technology dubbed “alternative splicing” to help patients restore their health and overcome their diseases and ailments. Their techniques would allow for tissue regeneration and significantly impact how we treat various diseases today.

• Location: Boston, Massachusetts
• Founders: Austin Che, Barry Canton, Jason Kelly, Reshma Shetty, Tom Knight
• Founded In: 2008
• Funding: Grant, $1.6 Billion
• Investors Include: Impede Capital, Viking Global Investors, Illumina

Ginkgo Bioworks is coining the phrase “biology by design” and working to program cells to make everything from therapeutics to materials to edible food. By using custom microbes and proprietary processes, Ginkgo is able to develop an array of cutting-edge biological engineering products and even custom microbes.

• Location: Pleasanton, California
• Founders: Ben Hindson, Serge Saxonov
• Founded In: 2012
• Funding: Series D, $242.6 Million
• Investors Include: Paladin Capital Group, Meritech Capital Partners, Fidelity

10x Genomics is a startup with the ambitious goal of advancing human health through the mastery of biology. They aim to accelerate their progress through research across life sciences, in situ products, and single cells.

• Location: Boston, Massachusetts
• Founders: Tony Coles
• Founded In: 2018
• Funding: Post-IPO Equity, $1.9 Billion
• Investors Include: Perceptive Advisors, Bain Capital, Novaquest Capital Management

Cerevel Therapeutics is a biotechnology company focused on unraveling all of the mysteries of the human brain in order to develop treatments for a variety of neurological diseases.

Recommended: Check out our full list of the top startups to watch in 2024!

Biotech startups are at the forefront of drug development and life sciences research. Combining the power of technologies such as artificial intelligence with things like induced pluripotent stem cells and gene therapies to change the world. Or they can be a technology company creating an operating system or making data accessible for other innovative biotech companies.

Whatever sector they are innovative in, these biotech startups are changing the way patients are treated for illnesses and transforming the industry as a whole.